Vivanza Biosciences consolidated net profit declines 66.67% in the June 2025 quarter
Sales rise 266.39% to Rs 8.94 crore
Net profit of Vivanza Biosciences declined 66.67% to Rs 0.09 crore in the quarter ended June 2025 as against Rs 0.27 crore during the previous quarter ended June 2024. Sales rose 266.39% to Rs 8.94 crore in the quarter ended June 2025 as against Rs 2.44 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales8.942.44 266 OPM %1.6814.75 -PBDT0.090.27 -67 PBT0.090.27 -67 NP0.090.27 -67Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2025 | 5:55 PM IST